AF
PFE icon

Ally Financial’s Pfizer PFE Stock Holding History

Ally Financial’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.5M Hold
446,000
– – 1.56% 13
2025
Q4 		$11.1M Hold
446,000
– – 1.36% 13
2025
Q3 		$11.4M Hold
446,000
– – 1.4% 13
2025
Q2 		$10.8M Buy
446,000
+123,000
+38% +$2.87M 1.22% 13
2025
Q1 		$8.18M Hold
323,000
– – 0.92% 23
2024
Q4 		$8.57M Hold
323,000
– – 1.05% 18
2024
Q3 		$9.35M Hold
323,000
– – 1.13% 18
2024
Q2 		$9.04M Hold
323,000
– – 1.12% 22
2024
Q1 		$8.96M Buy
323,000
+38,000
+13% +$1.05M 1.21% 24
2023
Q4 		$8.21M Buy
285,000
+119,000
+72% +$3.6M 1.07% 24
2023
Q3 		$5.51M Buy
166,000
+41,000
+33% +$1.45M 0.81% 33
2023
Q2 		$4.58M Buy
+125,000
New +$4.87M 0.64% 38
2022
Q2 		– Sell
-120,000
Closed -$6.21M – 122
2022
Q1 		$6.21M Buy
120,000
+2,000
+2% +$104K 0.72% 38
2021
Q4 		$6.97M Buy
118,000
+63,000
+115% +$3.12M 0.64% 40
2021
Q3 		$2.37M Sell
55,000
-304,000
-85% -$13.5M 0.23% 86
2021
Q2 		$14.1M Hold
359,000
– – 1.4% 18
2021
Q1 		$13M Buy
359,000
+14,000
+4% +$497K 1.24% 21
2020
Q4 		$12.7M Buy
345,000
+44,610
+15% +$1.64M 1.19% 23
2020
Q3 		$10.5M Hold
300,390
– – 1.68% 13
2020
Q2 		$9.32M Buy
300,390
+47,430
+19% +$1.61M 1.53% 11
2020
Q1 		$7.83M Buy
252,960
+63,240
+33% +$2.15M 0.84% 15
2019
Q4 		$7.05M Buy
189,720
+10,540
+6% +$375K 1.16% 23
2019
Q3 		$6.11M Buy
179,180
+26,350
+17% +$958K 1.09% 25
2019
Q2 		$6.28M Hold
152,830
– – 1.08% 23
2019
Q1 		$6.16M Buy
152,830
+100,130
+190% +$4.01M 1.17% 22
2018
Q4 		$2.18M Buy
+52,700
New +$2.19M 0.28% 74
2018
Q3 		– Sell
-305,660
Closed -$10.5M – 125
2018
Q2 		$10.5M Buy
305,660
+15,810
+5% +$540K 2.07% 8
2018
Q1 		$9.76M Buy
289,850
+268,770
+1,275% +$9.24M 1.46% 17
2017
Q4 		$724K Sell
21,080
-279,310
-93% -$9.52M 0.14% 105
2017
Q3 		$10.2M Sell
300,390
-84,320
-22% -$2.71M 1.94% 11
2017
Q2 		$12.3M Buy
384,710
+84,320
+28% +$2.66M 2.43% 7
2017
Q1 		$9.75M Hold
300,390
– – 2.2% 11
2016
Q4 		$9.26M Hold
300,390
– – 1.56% 13
2016
Q3 		$9.65M Sell
300,390
-57,970
-16% -$1.94M 1.69% 12
2016
Q2 		$12M Buy
358,360
+79,050
+28% +$2.52M 2% 10
2016
Q1 		$7.86M Hold
279,310
– – 1.1% 23
2015
Q4 		$8.55M Buy
279,310
+31,620
+13% +$995K 1.19% 22
2015
Q3 		$7.38M Buy
247,690
+89,590
+57% +$2.87M 0.75% 33
2015
Q2 		$5.03M Sell
158,100
-184,450
-54% -$6.01M 0.51% 52
2015
Q1 		$11.3M Sell
342,550
-284,580
-45% -$9.05M 1.17% 24
2014
Q4 		$18.5M Hold
627,130
– – 2.05% 6
2014
Q3 		$17.6M Hold
627,130
– – 2.42% 5
2014
Q2 		$17.7M Buy
627,130
+216,070
+53% +$6.16M 2.08% 8
2014
Q1 		$12.5M Sell
411,060
-184,450
-31% -$5.5M 1.33% 19
2013
Q4 		$17.3M Sell
595,510
-152,830
-20% -$4.45M 1.84% 10
2013
Q3 		$20.4M Hold
748,340
– – 2.22% 7
2013
Q2 		$19.9M Buy
+748,340
New +$20.7M 1.96% 7

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Ally Financial's PFE Position: Q1 2026 in Review

Ally Financial held its Pfizer (PFE) position steady in Q1 2026 at 446,000 shares worth $12.5M. The position accounts for 1.56% of the portfolio, ranked #13.

Ally Financial first reported a position in PFE in Q2 2013 and has held it in 47 quarters since. The position peaked at $20.4M in Q3 2013. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Ally Financial held 446,000 shares of Pfizer worth $12.5M as of Q1 2026.
  • Ally Financial left its Pfizer share count unchanged in Q1 2026.
  • Pfizer made up 1.56% of Ally Financial's portfolio in Q1 2026, its #13 holding.
  • Ally Financial first reported a position in Pfizer in Q2 2013 and has held it in 47 quarters since.
  • Ally Financial's Pfizer position peaked at $20.4M in Q3 2013.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Ally Financial's 13F filing for Q1 2026, filed 12 May 2026.